92 related articles for article (PubMed ID: 2241961)
1. Protein kinase C and platelet inhibition by D-erythro-sphingosine: comparison with N,N-dimethylsphingosine and commercial preparation.
Khan WA; Dobrowsky R; el Touny S; Hannun YA
Biochem Biophys Res Commun; 1990 Oct; 172(2):683-91. PubMed ID: 2241961
[TBL] [Abstract][Full Text] [Related]
2. Use of D-erythro-sphingosine as a pharmacological inhibitor of protein kinase C in human platelets.
Khan WA; Mascarella SW; Lewin AH; Wyrick CD; Carroll FI; Hannun YA
Biochem J; 1991 Sep; 278 ( Pt 2)(Pt 2):387-92. PubMed ID: 1898331
[TBL] [Abstract][Full Text] [Related]
3. Weak inhibition of protein kinase C coupled with various non-specific effects make sphingosine an unsuitable tool in platelet signal transduction studies.
Krishnamurthi S; Patel Y; Kakkar VV
Biochim Biophys Acta; 1989 Feb; 1010(2):258-64. PubMed ID: 2492201
[TBL] [Abstract][Full Text] [Related]
4. Sphingosine inhibition of agonist-dependent secretion and activation of human platelets implies that protein kinase C is a necessary and common event of the signal transduction pathways.
Hannun YA; Greenberg CS; Bell RM
J Biol Chem; 1987 Oct; 262(28):13620-6. PubMed ID: 3115982
[TBL] [Abstract][Full Text] [Related]
5. Cell membrane signaling as target in cancer therapy. II: Inhibitory effect of N,N,N-trimethylsphingosine on metastatic potential of murine B16 melanoma cell line through blocking of tumor cell-dependent platelet aggregation.
Okoshi H; Hakomori S; Nisar M; Zhou QH; Kimura S; Tashiro K; Igarashi Y
Cancer Res; 1991 Nov; 51(22):6019-24. PubMed ID: 1657377
[TBL] [Abstract][Full Text] [Related]
6. N,N-dimethylsphingosine inhibition of sphingosine kinase and sphingosine 1-phosphate activity in human platelets.
Yatomi Y; Ruan F; Megidish T; Toyokuni T; Hakomori S; Igarashi Y
Biochemistry; 1996 Jan; 35(2):626-33. PubMed ID: 8555236
[TBL] [Abstract][Full Text] [Related]
7. Sphingosylphosphorylcholine, a naturally occurring lipid mediator, inhibits human platelet function.
Altmann C; Meyer Zu Heringdorf D; Böyükbas D; Haude M; Jakobs KH; Michel MC
Br J Pharmacol; 2003 Feb; 138(3):435-44. PubMed ID: 12569068
[TBL] [Abstract][Full Text] [Related]
8. N,N-dimethylsphingosine 1-phosphate activates human platelets.
Yatomi Y; Yamamura S; Ruan F; Kume S; Ozaki Y; Igarashi Y
FEBS Lett; 1997 Nov; 417(3):341-4. PubMed ID: 9409747
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine enhances platelet aggregation through an increase in phospholipase C activity by a protein kinase C-independent mechanism.
Hashizume T; Sato T; Fujii T
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):243-7. PubMed ID: 1540140
[TBL] [Abstract][Full Text] [Related]
10. Response of aequorin-loaded platelets to activators of protein kinase C.
Ware JA; Saitoh M; Smith M; Johnson PC; Salzman EW
Am J Physiol; 1989 Jan; 256(1 Pt 1):C35-43. PubMed ID: 2912135
[TBL] [Abstract][Full Text] [Related]
11. Sphingosine 1-phosphate formation and intracellular Ca2+ mobilization in human platelets: evaluation with sphingosine kinase inhibitors.
Yang L; Yatomi Y; Satoh K; Igarashi Y; Ozaki Y
J Biochem; 1999 Jul; 126(1):84-9. PubMed ID: 10393324
[TBL] [Abstract][Full Text] [Related]
12. A specific enhancing effect of N,N-dimethylsphingosine on epidermal growth factor receptor autophosphorylation. Demonstration of its endogenous occurrence (and the virtual absence of unsubstituted sphingosine) in human epidermoid carcinoma A431 cells.
Igarashi Y; Kitamura K; Toyokuni T; Dean B; Fenderson B; Ogawass T; Hakomori S
J Biol Chem; 1990 Apr; 265(10):5385-9. PubMed ID: 2318819
[TBL] [Abstract][Full Text] [Related]
13. N,N-dimethylsphingosine phosphorylation in human platelets.
Yatomi Y; Ozaki Y; Satoh K; Kume S; Ruan F; Igarashi Y
Biochem Biophys Res Commun; 1997 Feb; 231(3):848-51. PubMed ID: 9070908
[TBL] [Abstract][Full Text] [Related]
14. The fibrinogen-derived peptide (RGDS) prevents proteolytic degradation of protein kinase C in platelets by inhibiting platelet aggregation.
Krishnamurthi S; Dickens TA; Patel Y; Wheeler-Jones CP; Kakkar VV
Biochem Biophys Res Commun; 1989 Sep; 163(3):1256-64. PubMed ID: 2783136
[TBL] [Abstract][Full Text] [Related]
15. Effect of chemically well-defined sphingosine and its N-methyl derivatives on protein kinase C and src kinase activities.
Igarashi Y; Hakomori S; Toyokuni T; Dean B; Fujita S; Sugimoto M; Ogawa T; el-Ghendy K; Racker E
Biochemistry; 1989 Aug; 28(17):6796-800. PubMed ID: 2479412
[TBL] [Abstract][Full Text] [Related]
16. A concise synthesis of a promising protein kinase C inhibitor: D-erythro-sphingosine.
Pham VT; Joo JE; Tian YS; Oh CY; Ham WH
Arch Pharm Res; 2007 Jan; 30(1):22-7. PubMed ID: 17328238
[TBL] [Abstract][Full Text] [Related]
17. Quantification of sphingosine derivatives in human platelets: inducible formation of free sphingosine.
Hisano N; Yatomi Y; Fujino MA; Igarashi Y; Kume S; Ozaki Y
J Biochem; 1998 Feb; 123(2):263-8. PubMed ID: 9538201
[TBL] [Abstract][Full Text] [Related]
18. Sphingosine inhibition of protein kinase C activity and of phorbol dibutyrate binding in vitro and in human platelets.
Hannun YA; Loomis CR; Merrill AH; Bell RM
J Biol Chem; 1986 Sep; 261(27):12604-9. PubMed ID: 3462188
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of sphingosine kinase in vitro and in platelets. Implications for signal transduction pathways.
Buehrer BM; Bell RM
J Biol Chem; 1992 Feb; 267(5):3154-9. PubMed ID: 1310683
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and evaluation of sphingoid analogs as inhibitors of sphingosine kinases.
Kim JW; Kim YW; Inagaki Y; Hwang YA; Mitsutake S; Ryu YW; Lee WK; Ha HJ; Park CS; Igarashi Y
Bioorg Med Chem; 2005 May; 13(10):3475-85. PubMed ID: 15848761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
